TFF Pharmaceuticals Announces Positive Preclinical Data from Bivalent Universal Influenza Vaccine Candidates Manufactured by TFF Following Intranasal Immunization

Link Type
Funded-research
Media Type
Article
Publish or Event Date
Link URL
https://tffpharma.com/press_releases/tff-pharmaceuticals-announces-positive-preclinical-data-from-bivalent-universal-influenza-vaccine-candidates-manufactured-by-tff-following-intranasal-immunization/
Research Institution
TFF Pharmaceuticals
Short Title
TFF Pharmaceuticals Announces Positive Preclinical Data
Content Coordinator
Claudia Wair
Content Manager
Jennifer Routh